Met Life Investment Management, LLC Vera Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 26,803 shares of VERA stock, worth $725,825. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,803
Previous 22,778
17.67%
Holding current value
$725,825
Previous $1.01 Million
12.62%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding VERA
# of Institutions
192Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$152 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$119 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$90.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$80.2 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$79.9 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $732M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...